Company Description
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs.
It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.
The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents.
The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms.
The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes.
The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Country | United States |
Founded | 2023 |
Industry | Health Information Services |
Sector | Healthcare |
Employees | 22,000 |
CEO | Bryan C. Hanson |
Contact Details
Address: C/o 3m Company, 3m Center, Building 275-6w-02 St. Paul, Minnesota 55144-1000 United States | |
Phone | 651-733-1110 |
Website | solventum.com |
Stock Details
Ticker Symbol | SOLV |
Exchange | NYSE |
Fiscal Year | January - December |
CIK Code | 0001964738 |
CUSIP Number | 83444M101 |
ISIN Number | US83444M1018 |
Employer ID | 92-2008841 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Mary T. Wilcox | Chief Accounting Officer |
Amy Landucci | Chief Information and Digital Officer |
Paul S. Harrington | Chief Supply Chain Officer |
Michael J. Ottesen | Vice President |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 10, 2024 | 10-Q | Quarterly Report |
May 9, 2024 | 8-K | Current Report |
Apr 16, 2024 | 8-K | Current Report |
Apr 4, 2024 | 8-K | Current Report |
Apr 1, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
Mar 13, 2024 | 8-K | Current Report |
Mar 12, 2024 | CERT | Certification by an exchange approving securities for listing |
Mar 11, 2024 | 10-12B/A | Filing |
Mar 6, 2024 | 10-12B/A | Filing |
Mar 1, 2024 | UPLOAD | Filing |